AI-Rad Companion (Cardiovascular) vs Tempus ECG-AF
AI Verdict
Choose AI-Rad Companion (Cardiovascular) if…
Choose AI-Rad Companion (Cardiovascular) if your clinical workflow requires detailed, quantitative, and reproducible analysis of CT DICOM images for comprehensive cardiovascular assessment. This tool is ideal for physicians needing automated segmentation, volume measurements, and guideline-based diameter assessments of the heart and thoracic aorta to support diagnosis and treatment planning for a range of cardiovascular diseases.
View AI-Rad Companion (Cardiovascular) →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your objective is to proactively identify older patients (65+) at an elevated risk of developing new-onset atrial fibrillation or flutter within the next 12 months using standard 12-lead ECG recordings. This solution is best suited for screening and risk stratification in eligible patient populations to enable earlier intervention and follow-up for AF prevention and management.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-Rad Companion (Cardiovascular) | Tempus ECG-AF |
|---|---|---|
| Pricing | Contact vendor for pricing | Contact vendor |
| Deployment | Cloud-based (via teamplay digital health platform) and Edge deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AI-Rad Companion (Cardiovascular)AI-Rad Companion (Cardiovascular) emphasizes automatic post-processing and generation of standardized reports in DICOM SC format, directly streamlining the workflow for radiologists. Its seamless integration into existing PACS environments further enhances ease of use within established clinical practices. Tempus ECG-AF also integrates into healthcare systems but does not highlight the same level of workflow automation.
Clinical Value
Tempus ECG-AFTempus ECG-AF offers significant clinical value by identifying patients at increased risk of developing Atrial Fibrillation within 12 months, enabling earlier intervention and follow-up for a high-impact condition. While AI-Rad Companion provides comprehensive quantitative analysis for various cardiovascular diseases, Tempus ECG-AF's predictive capability for a specific, critical outcome offers a distinct and potentially higher impact on proactive patient management.
Pricing & Value
Tempus ECG-AFTempus ECG-AF clearly demonstrates superior pricing and value transparency by explicitly stating CMS reimbursement availability with specific CPT codes (0764T and 0765T) and a Medicare rate of $128.90. This provides a tangible financial benefit and clarity for healthcare providers considering adoption. AI-Rad Companion only states 'contact vendor for pricing,' offering no comparable financial details.
Enterprise Readiness
AI-Rad Companion (Cardiovascular)Siemens Healthineers, the company behind AI-Rad Companion, is a global leader with extensive experience in medical imaging and enterprise solutions, implying robust support and integration capabilities. Its deployment options (Cloud and Edge) and integration with the 'teamplay digital health platform' suggest a comprehensive and flexible enterprise-grade offering. While Tempus AI is also a strong player, Siemens' long-standing presence and broader infrastructure in healthcare provide a slight edge.
Innovation
Tempus ECG-AFTempus ECG-AF demonstrates a higher degree of innovation by leveraging AI for predictive risk identification of a future event (Atrial Fibrillation within 12 months) from standard ECG data. This moves beyond diagnostic assistance to proactive patient management and preventative care. AI-Rad Companion's innovation lies in automating and enhancing quantitative analysis of CT images, which is significant but less focused on future risk prediction.
Support & Docs
TieBoth tools are offered by established and reputable companies in the healthcare technology sector (Siemens Healthineers and Tempus AI). While the provided facts do not offer specific details on documentation or support channels for either product, it is reasonable to expect robust professional support and comprehensive documentation from both organizations for their enterprise-grade solutions. Therefore, a clear distinction cannot be made.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-Rad Companion (Cardiovascular) | Tempus ECG-AF |
|---|---|---|
| Tool Name | AI-Rad Companion (Cardiovascular) | Tempus ECG-AF |
| Company | Siemens Medical Solutions U. | Tempus AI, Inc. |
| Description | AI-powered image processing software that provides quantitative and qualitative analysis of CT DICOM images to support physicians in evaluating cardiovascular diseases. | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. |
| Primary Modality | CT DICOM images | 12-lead ECG recordings |
| Key Feature 1 | Automatic recognition and quantification of coronary calcium volume from CT images. | AI-based algorithm for 12-lead ECG analysis |
| Key Feature 2 | Automatic 3D overview and segmentation of the thoracic aorta. | Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months |
| Target Patient Population (if specified) | Not specified | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery |
Videos
Demos, reviews, and walkthroughs featuring AI-Rad Companion (Cardiovascular) and Tempus ECG-AF.